Vildagliptin more effectively achieves a composite endpoint of HbA1c<7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment

✍ Scribed by Bader, Giovanni; Geransar, Parnia; Schweizer, Anja

• Book ID: 123600589
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 306 KB
• Volume: 100
• Category: Article
• ISSN: 0168-8227
• DOI: 10.1016/j.diabres.2013.03.011